logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Clinical Drug Investigation cover

Clinical Drug Investigation

IF2.7
Papers206
Citations2979
Journal Papers 193
Publication Date
delete
Formulation-Specific Safety Issues of HIV Pre-exposure Prophylaxis Drugs: A Disproportionality Analysis of the FAERS Database
deleteClinical Drug Investigation
IF2.7
delete2026-10-10
delete0
PREAI
deleteDavide Rozza; Elisabetta Poluzzi; Ippazio Cosimo Antonazzo; Angela Boccia; Marco Paccini; Fortuna Gallucci; Domenico Ponticelli; Giulio Geraci; Fernando Agüero; Giampiero Mazzaglia; Lorenzo Giovanni Mantovani; Emanuel Raschi; Pietro Ferrara
deleteShare
deleteSave
Cognitive Outcomes After Reperfusion Therapy for Acute Ischaemic Stroke: A Systematic Review and Meta-analysis and the PRECISE-ACTION Framework for Transdisciplinary Cognitive Management
deleteClinical Drug Investigation
IF2.7
delete2026-10-05
delete0
PREAI
deleteSamprithi Raja; Robert Weissert; Zeljka Calic; Pravin Thomas; Jasvinder Chawla; Susana Mederer Hengstl; Ivica Smokovski; Olga Golubnitschaja; Tomotaka Tanaka; Kevin J. Spring; Murray C. Killingsworth; Man Mohan Mehndiratta; Rajesh N. Kalaria; Masafumi Ihara; Sonu M. M. Bhaskar
deleteShare
deleteSave
Serotonergic Toxicity and Hyponatremia Associated with Antidepressant Therapy: The Pivotal Role of SIADH
deleteClinical Drug Investigation
IF2.7
delete2026-10-03
delete0
deleteOAAI
deleteDonato Morena; Matteo Lippi; Letizia Biso; Federico Lucci; Emanuela Turillazzi; Vittorio Fineschi; Pasquale Scognamiglio
deleteShare
deleteSave
Proton Pump Inhibitor Co-prescription, Dabigatran Use, and Ischaemic Stroke or Transient Ischaemic Attack in Atrial Fibrillation: A Population-Based Case-Control Study
deleteClinical Drug Investigation
IF2.7
delete2026-10-03
delete0
deleteOAAI
deleteKarim M. Mahawish; Valery Feigin; Harvey White; Rita Krishnamurthi
deleteShare
deleteSave
Healthcare Cost Patterns in CDK4/6 Inhibitor-Treated HR+/HER2- Metastatic Breast Cancer
deleteClinical Drug Investigation
IF2.7
delete2026-09-28
delete0
deleteOAAI
deleteMunenobu Kashiwa; Kensuke Moriwaki
deleteShare
deleteSave
Symptomatic Interventions for Allergic Rhinitis Without Comorbid Asthma: A Dose-Stratified Network Meta-analysis
deleteClinical Drug Investigation
IF2.7
delete2026-09-19
delete0
PREAI
deleteSajjad Salimi; Arezoo Hamidi; Mohammad Mahdi Babajani; Amirreza Mohammadnejad; Alireza Rezaiemanesh
deleteShare
deleteSave
Real-World Treatment Patterns, Healthcare Resource Use, and Costs in Patients with Follicular Lymphoma, Waldenström Macroglobulinemia, and Marginal Zone Lymphoma: A Claims-Based Study in the USA
deleteClinical Drug Investigation
IF2.7
delete2026-09-19
delete0
deleteOAAI
deleteMahek Garg; Ambika Satija; Yan Song; Benjamin Meade; James Signorovitch; Shravanthi Gandra
deleteShare
deleteSave
A Randomized Four-Period Cross-Over Phase I Study to Assess Bioavailability, Bioequivalence, and Tolerability of IHL-42X Compared with the Reference Drugs in Healthy Volunteers
deleteClinical Drug Investigation
IF2.7
delete2026-09-12
delete0
deleteOAAI
deleteGeorge Williams Mbogo; Amanda Sallama; Parisa Asvadi; Natalie May; Emir Redzepagic; Philip Ryan; Mark Robert Bleackley
deleteShare
deleteSave
Dose-Dependent Association of Long-Term Metformin Use and Diabetic Nephropathy Risk in Patients with Type 2 Diabetes Mellitus: A Nationwide Population-Based Study in Taiwan
deleteClinical Drug Investigation
IF2.7
delete2026-09-12
delete0
deleteOAAI
deleteKuang-Hua Huang; Shuo-Yan Gau; Yu-Chia Chang; Zong-Han Lin; Tung-Han Tsai; Ya-Lan Chang; Chien-Ying Lee
deleteShare
deleteSave
The Great Transatlantic Divide: The Case of Experimental Neuropharmacology
deleteClinical Drug Investigation
IF2.7
delete2026-09-08
delete0
PREAI
deleteCarlo Colosimo
deleteShare
deleteSave
Statin Use and Arterial Calcification in the General Population: A Longitudinal Analysis and a Negative Control Population
deleteClinical Drug Investigation
IF2.7
delete2026-08-25
delete0
deleteOAAI
deleteMitra Nekouei Shahraki; Jeremy A Labrecque; Fariba Ahmadizar; Bruno H Stricker; Maryam Kavousi; Daniel Bos
deleteShare
deleteSave
Pharmacokinetics and Tolerability of Fexinidazole in Subjects with Hepatic Impairment
deleteClinical Drug Investigation
IF2.7
delete2026-08-19
delete0
deleteOAAI
deleteMatthieu Gassiot; Jean Pierre Beaucire; Sophie Hays; Sarah Lezzar; Céline Beauchard; Eric Sultan
deleteShare
deleteSave
Retrospective Real-World Comparison of Adherence, Persistence, Health-Care Utilization, and Costs Among Biologics for Moderate-to-Severe Psoriasis in China
deleteClinical Drug Investigation
IF2.7
delete2026-08-13
delete0
PREAI
deleteXiaoning He; Xiaoyang Xu; Xingzhi Wang; Jing Wu
deleteShare
deleteSave
Efficacy and Safety of Ustekinumab Biosimilars in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-analysis
deleteClinical Drug Investigation
IF2.7
delete2026-08-12
delete0
PREAI
deleteMohsin Rashid; Awon Muhammad; Eeraj Saeed; Ali Akram Qureshi; Mohammad Maheer Mubashir; Mohammad Waqas bin Waheed; Muhammad Abdullah Yasin; Muhammad Abdullah; Ahsan Rashid; Zainab Zubair
deleteShare
deleteSave
Modeling Cancer Outcomes and Economic Impact of the Anti-PD-1/PD-L1 Immunotherapy in the Gulf: United Arab Emirates, Oman, and Kuwait
deleteClinical Drug Investigation
IF2.7
delete2026-08-12
delete0
deleteOAAI
deleteHumaid O. Al-Shamsi; Mohamed Farghaly; Ammar Abdaljalil; Abdulwahab Al-Tourah; Chana Saad; Youmna Bassil; Ghadah Albassam; Rami Nimer; Monika Naroz; Omar El-Badry; Rony Akel
deleteShare
deleteSave
Cost Effectiveness of Teriparatide for Postmenopausal Osteoporosis: A Systematic Review
deleteClinical Drug Investigation
IF2.7
delete2026-08-08
delete0
PREAI
deleteMohammad Alimoradnori; Ali Abutorabi; Mozhdeh Zabihiyeganeh; Jalal Arabloo; Reza Jahanghiri
deleteShare
deleteSave
Operationalizing Single-Dose Long-Acting Lipoglycopeptides for Treatment of ABSSSI in a U.S. Community Hospital Emergency Department
deleteClinical Drug Investigation
IF2.7
delete2026-07-29
delete0
PREAI
deleteCole Orlikowski; Nicholas Torney; Aleah Hunt; William Britton; Cynthia Nichols
deleteShare
deleteSave
Signals of Venous Thromboembolism Risk from Drug–Drug Interactions Involving Benzodiazepines and Other Sedative Hypnotics: Self-Controlled Case Series Analyses
deleteClinical Drug Investigation
IF2.7
delete2026-07-29
delete0
deleteOAAI
deleteFengge Wang; Lin-Chieh Meng; Kacie Bogar; Colleen M. Brensinger; Warren B. Bilker; Sascha Dublin; Todd E. H. Hecht; John R. Horn; Daniela C. Moga; Michael E. Thase; Brian L. VanderBeek; Charles E. Leonard
deleteShare
deleteSave
Risk of Neurological Adverse Events Between PD-L1 and PD-1 Inhibitors in South Korean Patients with Lung Cancer: A Target Trial Emulation Framework
deleteClinical Drug Investigation
IF2.7
delete2026-07-27
delete0
deleteOAAI
deleteSang Hee Kim; Seung Hyeun Lee; Sukhyang Lee; Sun-Young Chang; Ha-Lim Jeon; Hankil Lee
deleteShare
deleteSave
Effect of Hepatic Impairment on the Pharmacokinetics of Single-Dose Viloxazine Extended-Release Capsules (Qelbree®) in Adults
deleteClinical Drug Investigation
IF2.7
delete2026-07-26
delete0
deleteOAAI
deleteZhao Wang; Toyin Adewole; Lilian W. Adeojo; Peibing Qin; Stefan Schwabe; Azmi Nasser
deleteShare
deleteSave